Investigating the longitudinal association between diabetes and anxiety: a systematic review and meta-analysis

Diabetic Medicine

Volumn 35, Issue 6, 2018, Pages 677-693

  Smith, K J ^a   Deschenes S S ^b,c   Schmitz, N ^b,c,d  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d Montreal Diabetes Research Center   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; DIABETES MELLITUS; DISEASE ASSOCIATION; HUMAN; INCIDENCE; META ANALYSIS; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; ADOLESCENT; ADULT; AGED; ANXIETY DISORDER; FEMALE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PSYCHOLOGY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANXIETY DISORDERS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 85044337595     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.13606     Document Type: Review

References (50)

1. International Diabetes Federation (IDF). International Diabetes Federation Atlas, 7th Edition. Brussels: IDF, 2015.
2. Balhara YPS. Diabetes and psychiatric disorders. Indian J Endocrin Metab 2011; 15: 274.
3. Ducat L, Philipson LH, Anderson BJ. The mental health comorbidities of diabetes. JAMA 2014; 312: 691–692.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5®). Washington, DC: American Psychiatric Association, 2013.
5. Bandelow B, Michaelis S. Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci 2015; 17: 327–335.
6. Martin P. The epidemiology of anxiety disorders: a review. Dialogues Clin Neurosci 2003; 5: 281–298.
7. Baxter A, Vos T, Scott K, Ferrari A, Whiteford H. The global burden of anxiety disorders in 2010. Psychol Med 2014; 44: 2363–2374.
8. Olatunji BO, Cisler JM, Tolin DF. Quality of life in the anxiety disorders: a meta-analytic review. Clin Psychol Rev 2007; 27: 572–581.
9. Roest AM, Martens EJ, de Jonge P, Denollet J. Anxiety and risk of incident coronary heart disease: a meta-analysis. J Am Coll Cardiol 2010; 56: 38–46.
10. Gariepy G, Nitka D, Schmitz N. The association between obesity and anxiety disorders in the population: a systematic review and meta-analysis. Int J Obes 2010; 34: 407.
11. Sardinha A, Nardi AE. The role of anxiety in metabolic syndrome. Expert Rev Endocrin Metab 2012; 7: 63–71.
12. Bonnet F, Irving K, Terra J-L, Nony P, Berthezène F, Moulin P. Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease. Atherosclerosis 2005; 178: 339–344.
13. Jansson-Fröjmark M, Lindblom K. A bidirectional relationship between anxiety and depression, and insomnia? A prospective study in the general population. J Psychosom Res 2008; 64: 443–449.
14. Nouwen A, Winkley K, Twisk J, Lloyd C, Peyrot M, Ismail K et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia 2010; 53: 2480–2486.
15. Katon WJ. Epidemiology and treatment of depression in patients with chronic medical illness. Dialogues Clin Neurosci 2011; 13: 7–23.
16. Turner J, Kelly B. Emotional dimensions of chronic disease. Western J Med 2000; 172: 124–128.
17. Grigsby AB, Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. Prevalence of anxiety in adults with diabetes: a systematic review. J Psychosom Res 2002; 53: 1053–1060.
18. Smith KJ, Béland M, Clyde M, Gariépy G, Pagé V, Badawi G et al. Association of diabetes with anxiety: a systematic review and meta-analysis. J Psychosom Res 2013; 74: 89–99.
19. Pouwer F, Kupper N, Adriaanse MC. Does emotional stress cause type 2 diabetes mellitus? A review from the European Depression in Diabetes (EDID) Research Consortium. Discov Med 2010; 9: 112–118.
20. Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. 2009. Available at www.ohri.ca/programs/clinical_epidemiology/oxford.htm Last accessed 1 May 2017.
21. Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016; 355: i4919.
22. Abraham S, Shah NG, Roux AD, Hill-Briggs F, Seeman T, Szklo M et al. Trait anger but not anxiety predicts incident type 2 diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA). Psychoneuroendocrinology 2015; 60: 105–113.
23. Boyko EJMD, Jacobson IGMPH, Smith BPHD, Ryan MAKMD, Hooper TIMD, Amoroso PJMD et al. Risk of diabetes in U.S. military service members in relation to combat deployment and mental health. Diabetes Care 2010; 33: 1771–1777.
24. Demmer RT, Gelb S, Suglia SF, Keyes KM, Aiello AE, Colombo PC et al. Sex differences in the association between depression, anxiety, and type 2 diabetes mellitus. Psychosom Med 2015; 77: 467–477.
25. Deschênes SS, Burns RJ, Graham E, Schmitz N. Prediabetes, depressive and anxiety symptoms, and risk of type 2 diabetes: a community-based cohort study. J Psychosom Res 2016; 89: 85–90.
26. Edwards LE, Mezuk B. Anxiety and risk of type 2 diabetes: evidence from the Baltimore Epidemiologic Catchment Area Study. J Psychosom Res 2012; 73: 418–423.
27. Farvid MS, Qi L, Hu FB, Kawachi I, Okereke OI, Kubzansky LD et al. Phobic anxiety symptom scores and incidence of type 2 diabetes in US men and women. Brain Behav Immun 2014; 36: 176–182.
28. Khambaty T, Callahan CM, Perkins AJ, Stewart JC. Depression and anxiety screens as simultaneous predictors of 10-year incidence of diabetes mellitus in older adults in primary care. J Am Geriatr Soc 2017; 65: 294–300.
29. Marrie RA, Patten SB, Greenfield J, Svenson LW, Jette N, Tremlett H et al. Physical comorbidities increase the risk of psychiatric comorbidity in multiple sclerosis. Brain Behav 2016; 6: e00493.
30. Miller-Archie SA, Jordan HT, Ruff RR, Chamany S, Cone JE, Brackbill RM et al. Posttraumatic stress disorder and new-onset diabetes among adult survivors of the World Trade Center disaster. Prevent Med 2014; 66: 34–38.
31. Scherrer JF, Lustman PJ, Chrusciel T, Garfield LD, Freedland KE, Carney RM et al. Posttraumatic stress disorder is a risk factor for incident diabetes. Psychosom Med 2011; 73: A58.
32. Vaccarino V, Goldberg J, Magruder KM, Forsberg CW, Friedman MJ, Litz BT et al. Posttraumatic stress disorder and incidence of type-2 diabetes: a prospective twin study. J Psychiatr Res 2014; 56: 158–164.
33. Atlantis E, Vogelzangs N, Cashman K, Penninx BJWH. Common mental disorders associated with 2-year diabetes incidence: The Netherlands Study of Depression and Anxiety (NESDA). J Affect Disord 2012; 142(Suppl): S30–S35.
34. Engum A. The role of depression and anxiety in onset of diabetes in a large population-based study. J Psychosom Res 2007; 62: 31–38.
35. Pérez-Piñar M, Mathur R, Foguet Q, Ayis S, Robson J, Ayerbe L. Cardiovascular risk factors among patients with schizophrenia, bipolar, depressive, anxiety, and personality disorders. Eur Psychiat 2016; 35: 8–15.
36. Chien IC, Lin CH. Increased risk of diabetes in patients with anxiety disorders: A population-based study. J Psychosom Res 2016; 86: 47–52.
37. Shirom A, Toker S, Jacobson O, Balicer RD. Feeling vigorous and the risks of all-cause mortality, ischemic heart disease, and diabetes: a 20-year follow-up of healthy employees. Psychosom Med 2010; 72: 727–733.
38. Huang CJ, Wang SY, Lee MH, Chiu HC. Prevalence and incidence of mental illness in diabetes: a national population-based cohort study. Diabetes Res Clin Pract 2011; 93: 106–114.
39. Stavrakaki C, Vargo B. The relationship of anxiety and depression: a review of the literature. Br J Psychiatry 1986; 149: 7–16.
40. Culpepper L. Generalized anxiety disorder and medical illness. J Clin Psychiatry 2009; 70(Suppl 2): 20–24.
41. Cooper M, Lin A, Alvares G, de Klerk N, Jones T, Davis E. Psychiatric disorders during early adulthood in those with childhood onset type 1 diabetes: rates and clinical risk factors from population-based follow-up. Pediatr Diabetes 2017; 18: 599–606.
42. Hasan SS, Clavarino AM, Dingle K, Mamun AA, Kairuz T. Diabetes mellitus and the risk of depressive and anxiety disorders in Australian women: a longitudinal study. J Women's Health (Larchmt) 2015; 24: 889–898.
43. Nandi A, Beard JR, Galea S. Epidemiologic heterogeneity of common mood and anxiety disorders over the lifecourse in the general population: a systematic review. BMC Psychiatry 2009; 9: 31.
44. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiat 2005; 62: 593–602.
45. Rotella F, Mannucci E. Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies. J Clin Psychiatry 2013; 74: 31–37.
46. Vancampfort D, Rosenbaum S, Ward PB, Steel Z, Lederman O, Lamwaka AV et al. Type 2 diabetes among people with posttraumatic stress disorder: systematic review and meta-analysis. Psychosom Med 2016; 78: 465–473.
47. Lustman PJ, Anderson RJ, Freedland KE, De Groot M, Carney RM, Clouse RE. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 2000; 23: 934–942.
48. Deschênes SS, Burns RJ, Schmitz N. Anxiety symptoms and functioning in a community sample of individuals with type 2 diabetes: a longitudinal study. J Diabetes 2016; 8: 854–862.
49. Collins M, Corcoran P, Perry I. Anxiety and depression symptoms in patients with diabetes. Diabet Med 2009; 26: 153–161.
50. Young-Hyman D, De Groot M, Hill-Briggs F, Gonzalez JS, Hood K, Peyrot M. Psychosocial care for people with diabetes: a position statement of the American Diabetes Association. Diabetes Care 2016; 39: 2126–2140.